Company / CapEx per Share
Arcus Biosciences, Inc. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.02
FY2025
5-year range
$0.02 / $0.40
FY2021-FY2025
Trend
-72.7%
vs FY2024
Sector context
#101 of 192
Health Care
What the data says
At $0.02, Arcus Biosciences, Inc.'s capex per share ranks #101 of 192 in the Health Care sector. CapEx per Share has fluctuated over the past 10 years, ranging from $0.02 in FY2025 to $4.74 in FY2016.
Based on SEC 10-K filings.
0.02 in FY2025 with a 5-year CAGR of -23.3%.
Declined from $0.33 to $0.02 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -20.0%
- 5-Year CAGR
- -23.3%
- 10-Year CAGR
- -
Sector benchmark
#101 of 192 in Health CareTop 53% of 192This company $0.02 Sector average $3.54
▼
-99.4% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 72.7% year-over-year.
- Ranks #101 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | -72.7% |
| FY2024 | $0.08 | -75.9% |
| FY2023 | $0.33 | +677.0% |
| FY2022 | $0.04 | -89.4% |
| FY2021 | $0.40 | +389.9% |
| FY2020 | $0.08 | +88.6% |
| FY2019 | $0.04 | -95.7% |
| FY2018 | $1.00 | -66.8% |
| FY2017 | $3.02 | -36.4% |
| FY2016 | $4.74 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026